tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gbola Amusa, 24 are a HOLD (17.27%), 100 are a BUY (71.94%), 15 are a SELL (10.79%).
Analyst Gbola Amusa, carries an average stock price target met ratio of 60.06% that have a potential upside of 65.57% achieved within 514 days. Previously, Gbola Amusa worked at CHARDAN CAPITAL.
Gbola Amusa’s has documented 256 price targets and ratings displayed on 32 stocks. The coverage was on Healthcare, Industrials, Communication Services sectors.
Most recent stock forecast was given on PASG, Passage Bio at 04-Mar-2025.
Analyst best performing recommendations are on ESPR (ESPERION THERAPEUTICS).
The best stock recommendation documented was for ESPR (ESPERION THERAPEUTICS) at 1/31/2020. The price target of $65 was fulfilled within 10 days with a profit of $10.92 (20.19%) receiving and performance score of 20.19.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
$0.64 (14.68%)
7 months 21 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 01-Nov-2023
$5.5
$1.14 (26.15%)
$12
8 months 9 days ago
(29-Oct-2025)
1/7 (14.29%)
$1.27 (30.02%)
292
Hold Since 16-Apr-2025
$4
$-0.36 (-8.26%)
$5
8 months 10 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
10 months 25 days ago
(13-Aug-2025)
2/3 (66.67%)
$30.52 (321.94%)
1046
Hold Since 19-Mar-2024
$4
$-0.36 (-8.26%)
$5
1 years 1 months 23 days ago
(15-May-2025)
4/6 (66.67%)
$1.95 (95.12%)
205
What Year was the first public recommendation made by Gbola Amusa?
